ES2038093T1 - Uso del enantiomero s(+) ibuprofeno. - Google Patents

Uso del enantiomero s(+) ibuprofeno.

Info

Publication number
ES2038093T1
ES2038093T1 ES199090905892T ES90905892T ES2038093T1 ES 2038093 T1 ES2038093 T1 ES 2038093T1 ES 199090905892 T ES199090905892 T ES 199090905892T ES 90905892 T ES90905892 T ES 90905892T ES 2038093 T1 ES2038093 T1 ES 2038093T1
Authority
ES
Spain
Prior art keywords
ibuprofen
mammalian
principle
enantiomer
ibuprofen enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES199090905892T
Other languages
English (en)
Inventor
Abraham Apt. 12D Sunshine
Eugene M. Laska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ES2038093T1 publication Critical patent/ES2038093T1/es
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE OBTIENE UNA RESPUESTA ANTIPIRETICA ACELERADA E INTENSIFICADA AL PRINCIPIO EN UN ORGANISMO DE UN MAMIFERO QUE NECESITA TAL TRATAMIENTO, ES DECIR, UN MAMIFERO QUE TIENE UNA TEMPERATURA CORPORAL ELEVADA (FIEBRE), MEDIANTE LA ADMINISTRACION AL MISMO DE UNA CANTIDAD EFICAZ ANTIPIRETICAMENTE ACELERADORA/INTENSIFICADORA AL PRINCIPIO DE UNA DOSIS UNITARIA DEL ENASTIOMERO DE IBUPROFENO S(T), ESTANDO DICHO ENANTIOMERO SUSTANCIALMENTE LIBRE DE SU ANTIPODO DE IBUPROFENO R(-).
ES199090905892T 1989-05-25 1990-04-04 Uso del enantiomero s(+) ibuprofeno. Pending ES2038093T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/356,850 US4980375A (en) 1987-07-10 1989-05-25 Onset-hastened/enhanced antipyretic response

Publications (1)

Publication Number Publication Date
ES2038093T1 true ES2038093T1 (es) 1993-07-16

Family

ID=23403222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199090905892T Pending ES2038093T1 (es) 1989-05-25 1990-04-04 Uso del enantiomero s(+) ibuprofeno.

Country Status (9)

Country Link
US (1) US4980375A (es)
EP (1) EP0473604A4 (es)
JP (1) JPH04505758A (es)
KR (1) KR920700630A (es)
AU (1) AU630687B2 (es)
CA (1) CA2057034C (es)
ES (1) ES2038093T1 (es)
NZ (1) NZ233750A (es)
WO (1) WO1990014081A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8764191A (en) * 1990-09-28 1992-04-28 Mcneill-Ppc Inc. Ibuprofen-antihistamine combinations
EP0577757A1 (en) * 1991-04-01 1994-01-12 Merck & Co. Inc. Ibuprofen-decongestant combinations
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5718919A (en) * 1995-02-24 1998-02-17 Nanosystems L.L.C. Nanoparticles containing the R(-)enantiomer of ibuprofen
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
EP2445486B1 (en) * 2009-06-22 2017-11-08 Wyeth LLC Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701470A (en) * 1982-12-06 1987-10-20 The Upjohn Company Treatment of Type II Herpes virus with ibuprofen
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
DE3437599A1 (de) * 1984-10-13 1986-04-17 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
AU630687B2 (en) 1992-11-05
CA2057034A1 (en) 1990-11-26
EP0473604A1 (en) 1992-03-11
US4980375A (en) 1990-12-25
NZ233750A (en) 1997-06-24
EP0473604A4 (en) 1992-04-15
JPH04505758A (ja) 1992-10-08
WO1990014081A1 (en) 1990-11-29
AU5358890A (en) 1990-12-18
KR920700630A (ko) 1992-08-10
CA2057034C (en) 1999-04-13

Similar Documents

Publication Publication Date Title
ES2038093T1 (es) Uso del enantiomero s(+) ibuprofeno.
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
ATE89179T1 (de) Injektionsvorrichtung mit einer verformbaren ampulle.
ES531633A0 (es) Un procedimiento para la preparacion de una composicion liquida que contiene un generador se poroxiacido y peroxido de hidrogeno o un adicto del mismo.
ES2180541T3 (es) Nueva fosfolipasa a1, procedimiento para su preparacion y uso de la misma.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
NO873448L (no) Festeboeyle, saerlig for osteosyntese.
ES2072392T3 (es) Composicion blanqueante.
ATE116857T1 (de) Oligodesoxynukleotide als inhibitoren der replikation von retroviren und der expression von onkogenen.
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
MX9301753A (es) Generacion in vitro de celulas dentriticas humanas y utilizacion de las mismas.
ES2166403T3 (es) Prenda de retencion de desperdicios, de un solo uso.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
AR245684A1 (es) Procedimiento mejorado de hidrogenolisis/deshidrohalogenacion
MX9201218A (es) Procedimiento para la preparacion de 2,2-dicloro-1,1,1-trifluoro etano, 2-cloro-1,1,1,2- tetra fluoro etano y penta fluoro etano.
GB2380939B (en) Treatment or prevention of auto-immune diseases
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2176805T3 (es) Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
SE9202428L (sv) Inlaegg, inlaeggsbaerare och foerfarande foer tandrestaurering samt tandrestaureringsset foer genomfoerande av foerfarandet
ES2037278T3 (es) Tratamiento de la esterilidad.
ATE72103T1 (de) Elastische kniebandage.
ES2063876T3 (es) Transformador piezoceramico.
ES2012020A4 (es) Poliisoprenos con alta proporcion de unidades estructurales 1,2 y 3,4, procedimiento para su preparacion y su empleo.
GB9227123D0 (en) Method